{"id":"allergen","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT02966938","NCT01407835","NCT01597752","NCT02382718","NCT00293904","NCT00777374","NCT00290368","NCT07489040","NCT00200850","NCT06126692","NCT03414801","NCT01689571","NCT00795951","NCT00619827","NCT02661854","NCT06103656","NCT01286129","NCT00410280","NCT01113697","NCT03504774","NCT01087515","NCT00638755","NCT04442932","NCT00927329","NCT01984541","NCT04554498","NCT04958616","NCT00311844","NCT00640250","NCT07269509","NCT01691612","NCT01224834","NCT04641130","NCT03049111","NCT00448851","NCT06957496","NCT00339573","NCT06533462","NCT06527937","NCT06732414","NCT03388866","NCT02328170","NCT01739322","NCT00987272","NCT01378624","NCT01923779","NCT02005627","NCT02336542","NCT04663880","NCT02443805"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"brandName":"Allergen","companyId":"university-of-chicago","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Biologic","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"University of Chicago","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Allergen","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02966938","phase":"N/A","title":"Visual Recognition of Allergens by Allergic Patients and/or Their Parents","status":"COMPLETED","sponsor":"Lille Catholic University","isPivotal":false,"enrollment":440,"indication":"Nut Allergy, Peanut Allergy","completionDate":"2016-03"},{"nctId":"NCT01407835","phase":"Phase 2","title":"Biological Standardization of Dactylis Glomerata Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","isPivotal":false,"enrollment":31,"indication":"Allergy to Grass Pollen (Dactylis Glomerata)","completionDate":"2012-06"},{"nctId":"NCT01597752","phase":"Phase 2","title":"Biological Standardization of Blomia Tropicalis Allergen Extract to Determine the Biological Activity in Histamine Equivalent Prick (HEP) Units","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","isPivotal":false,"enrollment":20,"indication":"Allergy to Mites","completionDate":"2012-09"},{"nctId":"NCT02382718","phase":"Phase 2","title":"A Multinational Phase IIb Study to Investigate the Efficacy and Safety of Subcutaneous Immunotherapy With a Modified Fish- Parvalbumin Given in Single Rising and Maintenance Doses to Subjects Allergic","status":"COMPLETED","sponsor":"George Stavroulakis","isPivotal":false,"enrollment":45,"indication":"Food Allergy to Fish","completionDate":"2017-04"},{"nctId":"NCT00293904","phase":"Phase 1","title":"Safety, Immunogenicity and Clinical Efficacy of an Allergen Vaccine (CYT005-AllQbG10) in Subjects With Seasonal Rhinoconjunctivitis Due to Grass-Pollen Allergy","status":"COMPLETED","sponsor":"Cytos Biotechnology AG","isPivotal":false,"enrollment":36,"indication":"Hypersensitivity","completionDate":"2007-02"},{"nctId":"NCT00777374","phase":"Phase 2","title":"Single Center Phase I/IIa, Placebo Controlled, Randomized, Double-blind Preseasonal Study to Assess Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Al","status":"COMPLETED","sponsor":"University of Zurich","isPivotal":false,"enrollment":97,"indication":"Allergic Rhinoconjunctivitis","completionDate":"2010-11"},{"nctId":"NCT00290368","phase":"Phase 2","title":"Assessment of Inflammatory Mediator and Cellular Changes Following Repeated Nasal Allergen Challenge in Subjects With Allergic Rhinitis Sensitive to Timothy Grass Pollen - a Validation Study","status":"COMPLETED","sponsor":"Imperial College London","isPivotal":false,"enrollment":22,"indication":"Hayfever","completionDate":"2006-05"},{"nctId":"NCT07489040","phase":"NA","title":"Multi-component Package for Skin Health and Allergen Exposure Strategy to Prevent Food Allergy","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","isPivotal":false,"enrollment":64,"indication":"Allergy and Immunology","completionDate":"2028-12-31"},{"nctId":"NCT00200850","phase":"NA","title":"Sublingual Immunotherapy in Dust Mite Allergy","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","isPivotal":false,"enrollment":31,"indication":"Asthma","completionDate":"2008-10"},{"nctId":"NCT06126692","phase":"N/A","title":"3TR Asthma Biologics Cohort (ABC) Study - A Part of the 3TR (Taxonomy, Treatment, Targets and Remission) Consortium for the Identification of the Molecular Mechanisms of Non-response to Treatment, Rel","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","isPivotal":false,"enrollment":600,"indication":"Severe Asthma","completionDate":"2033-08"},{"nctId":"NCT03414801","phase":"NA","title":"A Single-Group Study Evaluating Reproducibility of Rhinitis Symptoms Induced by Cat Allergen (Fel d1) Exposure in the Red Maple Trials Natural Exposure Chamber (NEC) ™ in Subjects With Cat Allergy","status":"COMPLETED","sponsor":"Red Maple Trials Inc.","isPivotal":false,"enrollment":6,"indication":"Allergic Rhinitis, Rhinoconjunctivitis","completionDate":"2018-07-30"},{"nctId":"NCT01689571","phase":"Phase 2","title":"A Randomised, Double-blind, Placebo-controlled, Three-way Crossover Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Two Doses of Inhaled CHF6001 DPI After 9 Days of","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","isPivotal":false,"enrollment":36,"indication":"Asthma","completionDate":"2013-04"},{"nctId":"NCT00795951","phase":"Phase 4","title":"Clinical Evaluation of T.R.U.E. TEST® Panel 1.1, 2.1 and 3.1: in Children and Adolescents","status":"COMPLETED","sponsor":"Allerderm","isPivotal":false,"enrollment":102,"indication":"Dermatitis, Contact","completionDate":"2009-11"},{"nctId":"NCT00619827","phase":"Phase 1","title":"A Randomised, Double-blind, in Parallel Groups Placebo-controlled, Mono-centre, Phase I Study to Assess After Allergen Challenge in an Allergen Exposition Chamber the Effect and Its Time Course of Sub","status":"COMPLETED","sponsor":"Stallergenes Greer","isPivotal":false,"enrollment":89,"indication":"Seasonal Allergic Rhinitis","completionDate":"2008-03"},{"nctId":"NCT02661854","phase":"Phase 2","title":"Double Blind, Placebo-controlled, Dose Finding, Prospective, Multicenter Clinical Trial for the Treatment of Rhinitis/Rhinoconjunctivitis Against a Mixture of Dermatophagoides Pteronyssinus and Dermat","status":"UNKNOWN","sponsor":"Inmunotek S.L.","isPivotal":false,"enrollment":186,"indication":"Rhinitis, Rhinoconjunctivitis","completionDate":"2020-07"},{"nctId":"NCT06103656","phase":"Phase 2","title":"Double-Blind, Placebo-Controlled Phase 2 Study to Assess Safety and Efficacy of Chinese Herbal Therapy and Multiple Food Allergen Oral Immunotherapy","status":"COMPLETED","sponsor":"New York Medical College","isPivotal":false,"enrollment":33,"indication":"Food Allergy","completionDate":"2021-02-22"},{"nctId":"NCT01286129","phase":"NA","title":"Comparative Responses to Nasal Allergen Challenge in Allergic Rhinitic Subjects With or Without Asthma","status":"COMPLETED","sponsor":"Laval University","isPivotal":false,"enrollment":45,"indication":"Asthma, Allergic Rhinitis","completionDate":"2008-03"},{"nctId":"NCT00410280","phase":"Phase 2","title":"Allergen Challenge","status":"COMPLETED","sponsor":"Pfizer","isPivotal":false,"enrollment":30,"indication":"Asthma","completionDate":"2008-05"},{"nctId":"NCT01113697","phase":"N/A","title":"Molecular Mechanisms Involved in the Early and Late Responses to Allergen Challenge, in Asthmatic and Allergic Rhinitis Cohorts","status":"COMPLETED","sponsor":"University of British Columbia","isPivotal":false,"enrollment":520,"indication":"Asthma, Allergic Rhinitis","completionDate":"2023-12"},{"nctId":"NCT03504774","phase":"Phase 2","title":"T Cell Reagent Research for Monitoring T Cells in Food Allergy (MOTIF) Phase 2 Study Using Food Allergen Oral Immunotherapy for Shrimp or Cashew Allergies","status":"TERMINATED","sponsor":"Sayantani B. Sindher","isPivotal":false,"enrollment":58,"indication":"Allergy;Food, Allergy to Shrimp","completionDate":"2023-03-03"},{"nctId":"NCT01087515","phase":"NA","title":"Development and Validation of Magnetic Cell Separations Techniques Using a Good Manufacturing Practice (GMP) Grade Manufacturing Process for Clinical Applications and Generation of Pre-clinical Data","status":"COMPLETED","sponsor":"Fraunhofer-Institute of Toxicology and Experimental Medicine","isPivotal":false,"enrollment":20,"indication":"Asthma, Allergic Rhinitis","completionDate":"2011-11"},{"nctId":"NCT00638755","phase":"Phase 2","title":"A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Evaluate the Effect of Nasal Carbon Dioxide on Nasal Congestion Via Acoustic Rhinometry in Subjects With Perennial Allergic Rhini","status":"COMPLETED","sponsor":"Capnia, Inc.","isPivotal":false,"enrollment":20,"indication":"Perennial Allergic Rhinitis","completionDate":"2008-07"},{"nctId":"NCT04442932","phase":"N/A","title":"Validation of the abioSCOPE Device With an IgE Test Panel: Clinical Sensitivity and Specificity Study","status":"WITHDRAWN","sponsor":"Abionic SA","isPivotal":false,"enrollment":0,"indication":"Allergy, Allergic Asthma","completionDate":"2021-03-15"},{"nctId":"NCT00927329","phase":"Phase 1","title":"Evaluation of the Safety and Effect of an Allergen Challenge Procedure on Nasal Airway Inflammation in Allergic Individuals Using a Dermatophagoides Farinae Extract Nasal Allergen Challenge Protocol","status":"WITHDRAWN","sponsor":"University of North Carolina, Chapel Hill","isPivotal":false,"enrollment":0,"indication":"Dermatophagoides Farinae Allergy, Asthma","completionDate":"2017-04"},{"nctId":"NCT01984541","phase":"Phase 2","title":"Biological Standardization of Artemisia Vulgaris Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP).","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","isPivotal":false,"enrollment":30,"indication":"Allergy to Pollen","completionDate":"2014-09"},{"nctId":"NCT04554498","phase":"NA","title":"Toxins Removal and Inflammatory State modulAtion During Online Hemodiafiltration: Comparison of Two Different Dialyzers","status":"UNKNOWN","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","isPivotal":false,"enrollment":16,"indication":"Hemodialysis Complication, Inflammation","completionDate":"2024-05-01"},{"nctId":"NCT04958616","phase":"N/A","title":"Association Between House Dust Mites Sensitization and Level of Asthma Control and Severity in Children Attending Mansoura University Children's Hospital.","status":"COMPLETED","sponsor":"Mansoura University Children Hospital","isPivotal":false,"enrollment":60,"indication":"Bronchial Asthma","completionDate":"2019-03-01"},{"nctId":"NCT00311844","phase":"Phase 4","title":"A Double-blind, Placebo-controlled, Crossover, Single-center Study to Evaluate the Anti-allergic and Anti-inflammatory Effects of Multiple Doses of Desloratadine on Conjunctival Allergen Challenge-ind","status":"COMPLETED","sponsor":"Organon and Co","isPivotal":false,"enrollment":41,"indication":"Conjunctivitis, Allergic","completionDate":"2005-05-28"},{"nctId":"NCT00640250","phase":"Phase 2","title":"Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Bronopol and Disperse Blue 106 Dose Response Study","status":"COMPLETED","sponsor":"Allerderm","isPivotal":false,"enrollment":48,"indication":"Contact Dermatitis","completionDate":"2009-09"},{"nctId":"NCT07269509","phase":"NA","title":"Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Renmin Hospital of Wuhan University","isPivotal":false,"enrollment":276,"indication":"Allergic Rhinitis","completionDate":"2029-02-28"},{"nctId":"NCT01691612","phase":"Phase 2","title":"Role of the Isomerase Pin-1 in the Development and Treatment of Asthma","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","isPivotal":false,"enrollment":14,"indication":"Asthma","completionDate":"2015-05"},{"nctId":"NCT01224834","phase":"Phase 1","title":"Phase I Study to Investigate the Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy Tablets Given in Single Rising Doses and in Multi Dose Regimens to Subjects With an Allerg","status":"COMPLETED","sponsor":"Stallergenes Greer","isPivotal":false,"enrollment":60,"indication":"Rhinitis, Allergic, Seasonal, Ragweed Pollen Allergy","completionDate":"2009-10"},{"nctId":"NCT04641130","phase":"NA","title":"Validation and Reproducibility Study of the ALYATEC Allergen Exposure Chamber by Determining the Concentration of Birch Pollen Allergen Inducing Conjunctivitis in Subjects Allergic to Birch Pollen.","status":"COMPLETED","sponsor":"Alyatec","isPivotal":false,"enrollment":16,"indication":"Allergic Conjunctivitis","completionDate":"2017-09-11"},{"nctId":"NCT03049111","phase":"EARLY/Phase 1","title":"Screening Inhaled Allergen Challenge for Dermatophagoides Farinae","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","isPivotal":false,"enrollment":14,"indication":"Asthma","completionDate":"2019-10-03"},{"nctId":"NCT00448851","phase":"Phase 1","title":"Phase 1 Study of Dermatophagoides Farinae Inhalation in Humans","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","isPivotal":false,"enrollment":13,"indication":"Mild Asthma, Allergy","completionDate":"2009-10"},{"nctId":"NCT06957496","phase":"NA","title":"Phleum Pratense and Dactylis Glomerata Allergen Extracts. Determination of the in Vivo Histamine Equivalent Prick Test Units","status":"COMPLETED","sponsor":"Inmunotek S.L.","isPivotal":false,"enrollment":31,"indication":"Allergy Pollen, Allergic Reaction","completionDate":"2025-01-16"},{"nctId":"NCT00339573","phase":"N/A","title":"National Survey of Lead Hazards and Allergens in Housing","status":"COMPLETED","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","isPivotal":false,"enrollment":831,"indication":"Asthma, Allergy","completionDate":"1999-08-31"},{"nctId":"NCT06533462","phase":"NA","title":"Infant Food Allergen Oral Immunotherapy (InFO)","status":"RECRUITING","sponsor":"Karolinska Institutet","isPivotal":false,"enrollment":80,"indication":"Food Allergy, Oral Immunotherapy for Food Allergy","completionDate":"2027-12"},{"nctId":"NCT06527937","phase":"Phase 2","title":"A 2-Part, Phase 2, Open-Label, Randomized, Fixed Sequence Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Epinephrine After Single and Repeat Doses of DESF in Healthy Adults With Oral A","status":"COMPLETED","sponsor":"Aquestive Therapeutics","isPivotal":false,"enrollment":36,"indication":"Allergic Reaction","completionDate":"2024-10-13"},{"nctId":"NCT06732414","phase":"N/A","title":"A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-up","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":10000,"indication":"Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a","completionDate":"2045-11-01"},{"nctId":"NCT03388866","phase":"Phase 4","title":"Effect of Sublingual Immunotherapy With Mite Extract in Patients With Atopic Dermatits: Placebo-controlled Double-blind Randomized Study","status":"COMPLETED","sponsor":"Casa Espirita Terra de Ismael","isPivotal":false,"enrollment":91,"indication":"Atopic Dermatitis, Effects of Immunotherapy","completionDate":"2020-06-26"},{"nctId":"NCT02328170","phase":"N/A","title":"Comparative Study of Specific IgE Levels to Common Foods and Aeroallergens Among Thai Children Measured by EUROIMMUN Allergy and ImmunoCap","status":"COMPLETED","sponsor":"Mahidol University","isPivotal":false,"enrollment":235,"indication":"Allergy","completionDate":"2017-02"},{"nctId":"NCT01739322","phase":"Phase 2","title":"Biological Standardization of Platanus Acerifolia Allergen Extract to Determine the Biological Activity in HEP Units.","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","isPivotal":false,"enrollment":36,"indication":"Allergy to Platanus Acerifolia","completionDate":"2013-07"},{"nctId":"NCT00987272","phase":"Phase 3","title":"A Phase III Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the CAC Model of Acute Allergic Conjunctivitis in Japanese Subjects","status":"COMPLETED","sponsor":"Alcon Research","isPivotal":true,"enrollment":267,"indication":"Allergic Conjunctivitis","completionDate":"2009-11"},{"nctId":"NCT01378624","phase":"NA","title":"Ex Vivo Effect of Fragments and Modified Forms of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma and Pilo","status":"COMPLETED","sponsor":"Fraunhofer-Institute of Toxicology and Experimental Medicine","isPivotal":false,"enrollment":15,"indication":"Mild Intermittent Asthma (Gina 1)","completionDate":"2012-10"},{"nctId":"NCT01923779","phase":"N/A","title":"An Optional Follow-Up Study to Evaluate the Continued Efficacy of ToleroMune Grass in Grass Allergic Subjects Following Challenge With Grass Allergen in an Environmental Exposure Unit","status":"COMPLETED","sponsor":"Circassia Limited","isPivotal":false,"enrollment":163,"indication":"Grass Allergy, Rhinoconjunctivitis","completionDate":"2013-09"},{"nctId":"NCT02005627","phase":"Phase 2","title":"Randomised Placebo-controlled Study of Grass Pollen Allergen Immunotherapy Tablet (AIT) for Seasonal Rhinitis: Time Course of Nasal, Cutaneous and Immunological Outcomes","status":"COMPLETED","sponsor":"Imperial College London","isPivotal":false,"enrollment":46,"indication":"Allergic Rhinitis","completionDate":"2017-03-01"},{"nctId":"NCT02336542","phase":"Phase 2","title":"For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase IIb Clinical Research","status":"COMPLETED","sponsor":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","isPivotal":false,"enrollment":192,"indication":"Tuberculosis","completionDate":"2015-07"},{"nctId":"NCT04663880","phase":"NA","title":"Validation Study of the ALYATEC Allergen Exposure Chamber by Determining the Concentration of House Dust Mite Allergen Inducing Early and/or Late Bronchial Response in Asthmatic Subjects Allergic to M","status":"COMPLETED","sponsor":"Alyatec","isPivotal":false,"enrollment":27,"indication":"Allergic Asthma, Allergy to House Dust","completionDate":"2017-02-15"},{"nctId":"NCT02443805","phase":"Phase 3","title":"A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM","status":"COMPLETED","sponsor":"Stallergenes Greer","isPivotal":true,"enrollment":1607,"indication":"Rhinitis, Allergic, Perennial, House Dust Mite Allergy","completionDate":"2018-06-25"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Biologic","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":4,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}